Moleculin Biotech (MBRX) Reports Q3 Loss of $0.12/Share
Tweet
Share
E-mailGet Alerts MBRX Hot Sheet
Join SI Premium – FREE
Moleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
